|
NFIL3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.14040000010318E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.58409999953635E-07 |
| Normal-vs-Stage2 |
1.398260E-02 |
| Normal-vs-Stage3 |
5.982300E-03 |
| Normal-vs-Stage4 |
9.638500E-03 |
| Stage1-vs-Stage2 |
8.638400E-01 |
| Stage1-vs-Stage3 |
2.703800E-01 |
| Stage1-vs-Stage4 |
3.720000E-02 |
| Stage2-vs-Stage3 |
5.880800E-01 |
| Stage2-vs-Stage4 |
3.186400E-01 |
| Stage3-vs-Stage4 |
5.428000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.70219999989985E-07 |
| Normal-vs-AfricanAmerican |
3.599600E-02 |
| Normal-vs-Asian |
5.719800E-01 |
| Caucasian-vs-AfricanAmerican |
5.816000E-01 |
| Caucasian-vs-Asian |
1.521230E-01 |
| AfricanAmerican-vs-Asian |
2.491000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.806100E-04 |
| Normal-vs-Female |
2.54959999779203E-08 |
| Male-vs-Female |
7.754600E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.971770E-01 |
| Normal-vs-Age(41-60Yrs) |
3.8580999999982E-05 |
| Normal-vs-Age(61-80Yrs) |
1.61211999999411E-05 |
| Normal-vs-Age(81-100Yrs) |
6.266400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.916800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.239000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.495200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.498600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.953600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.963200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.640300E-03 |
| Normal-vs-Grade 2 |
1.61630000494739E-08 |
| Normal-vs-Grade 3 |
1.003690E-02 |
| Normal-vs-Grade 4 |
1.223670E-02 |
| Grade 1-vs-Grade 2 |
5.327600E-01 |
| Grade 1-vs-Grade 3 |
1.285680E-02 |
| Grade 1-vs-Grade 4 |
5.680300E-02 |
| Grade 2-vs-Grade 3 |
2.623600E-04 |
| Grade 2-vs-Grade 4 |
1.396040E-03 |
| Grade 3-vs-Grade 4 |
8.356800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.5309000450946E-09 |
| Normal-vs-ccB subtype |
1.773550E-02 |
| ccA subtype-vs-ccB subtype |
6.237600E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.94282999999018E-05 |
| Normal-vs-N1 |
6.569600E-01 |
| N0-vs-N1 |
4.264200E-02 |
|
|
